Interventional Study To Evaluate The Effect Of An Ayurvedic Tablet, Cream And Purgative Therapy On The Participants Of Psoriasis(Skin Condition)

A Single Arm Open Label Clinical Study To Evalute The Efficacy Of Khadira-Triphaladi Kasaya Ghanvati And Aragvadha Cream With Mridu Virechan In The Management Of Psoriasis In Children. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067843

Enrollment

Registered

2024-05-24

Start date

Unknown

Completion date

Unknown

Last updated

2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L989- Disorder of the skin and subcutaneous tissue, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of either sex in between age group of 10 to 16 years. 2.Patients presenting with clinical features of psoriasis. 3.Mild to Moderate psoriasis in affected area according to PASI Scale (1-69%) 4.Patient should be capable of obeying the instruction related to course of therapy

Exclusion criteria

Exclusion criteria: 1.Severe psoriasis in affected area according to PASI scale. (more than 70%) 2.Known case of Acute/Chronic Eczema and Leprosy. 3.Development of any allergic or hypersensitive signs and symptoms during the trial period (due to trialdrug).

Design outcomes

Primary

Measure	Time frame
1.Change in the scoring/grading of symptom of psoriasis in PASI scaleTimepoint: 4 MONTHS	—

Secondary

Measure	Time frame
1.Change in the APso-QOL parameter 2.To evaluate the safety of trial drug (Khadira- Triphaladi Kasaya Ghanvati and Aragvadha Cream) Timepoint: 4 months	—

Countries

India

Contacts

Public ContactDr Krishna Sharma

National Institute of Ayurveda Jaipur

vish123go@gmail.com8169436681

Outcome results